Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 试验地点
- 2
- 主要终点
- Optical Coherence Tomography: Retinal thickness
研究概览
简要总结
Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias
详细描述
After diagnose Yuxtafoveal telangiectasias secondary to Branch Retinal Vein Occlusion and with Idiopathic Ethiology by clinical signs and Fluorescein angiogram (FA)findings we treated patients with Intravitreal Injection of Bevacizumab (2.5mg/0.1ml). We performed a complete ophthalmological evaluation and at baseline and follow-up (1 and 3 months) we evaluate ETDRS Best Corrected visual acuity (BCVA), fluorescein angiogram (FA) and Optical Coherence Tomography (OCT)findings. We found an improvement in visual acuity and reduction of FA leakage and decrease retinal thickness in OCT.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Factorial
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Telangiectasias secondary to Branch Retinal Vein Occlusion
- •Patients with Idiopathic Juxtafoveal Retinal Telangiectasias
排除标准
- •Diabetic Retinopathy and Diabetic Macular Edema
- •Hypertensive Retinopathy
- •Choroidal Neovascularization
结局指标
主要结局
Optical Coherence Tomography: Retinal thickness
Best corrected Visual Acuity
Fluorescein Angiogram: Leakage
次要结局
未报告次要终点